Kroll Mark W
- SEC CIK
- 0001259254
In the past year, 1 open-market purchase filing worth $98.8K and no sales.
Current role at each company
- HAE Haemonetics CorpDirectoras of Jul 28, 2026
- AXON Axon Enterprise, Inc.Directoras of May 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $98.8K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$98.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kroll Mark W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HAE Haemonetics Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 (view filing) | Nov 10 | 2 days | Kroll Mark WDirector | PPurchase | +1.40K | $70.56 | +$98.8K | +6.0%24.8K after | |
| Aug 16, 2022 (view filing) | Aug 15 | 1 day | Kroll Mark WDirector | SSale | −8.02K | $73.71 | −$590.9K | −33.1%16.2K after |
AXON Axon Enterprise, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | Kroll Mark WDirector | SSale | −3.55K | $220.72 | −$783.3K | −25.9%10.1K after | 2 lots |
| Jun 9, 2022 (view filing) | Jun 8 | 1 day | Kroll Mark WDirector | SSale | −3.16K | $102.82 | −$324.8K | −18.7%13.7K after |